News お知らせ

2018年の英文業績

投稿者 : HP管理者

カテゴリ : 学術情報

 2018年の当教室の英文業績です。全部で11編ありました。*はcorrespondence author

1. *Inoue T, Nishimura A, Sasai K, Kitagawa T: A randomized, 8-week, double-blind, placebo-controlled trial of vortioxetine in Japanese adults with major depressive disorder, followed by a 52-week open-label extension trial. Psychiatry and Clinical Neurosciences 72:103-115, 2018.  DOI: 10.1111/pcn.12623

2. *Toda H, *Inoue T, Tanichi M, Saito T, Nakagawa S, Masuya J, Tanabe H, Yoshino A, Kusumi I: Affective temperaments play an important role in the relationship between child abuse and the diagnosis of bipolar disorder. Psychiatry Research 262:13-19, 2018. doi.org/10.1016/j.psychres.2018.01.040

3. *Shimura A, Hideo S, Takaesu Y, Nomura R, Komada Y, Inoue T: Comprehensive assessment of the impact of life habits on sleep disturbance, chronotype, and daytime sleepiness among high-school students. Sleep Med 44:12-18, 2018. DOI: 10.1016/j.sleep.2017.10.011

4. *Takaesu Y, Inoue Y, Ono K, Murakoshi A, Futenma K, Komada Y, Inoue T: Circadian rhythm sleep-wake disorders predict shorter time to relapse of mood episodes in euthymic patients with bipolar disorder: a prospective 48-week study. J Clin Psychiatry 79(1):17m11565, 2018. [Epub ahead of print] DOI: 10.4088/JCP.17m11565.

5. *Matsuo K, Harada K, Fujita Y, Okamoto Y, Ota M, Narita H, Mwangi B, Gutierrez CA, Okada G, Takamura M, Yamagata H, Kusumi I, Kunugi H, Inoue T, C. Soares J, Yamawaki S, Watanabe Y: Distinctive neuroanatomical substrates for depression in bipolar disorder versus major depressive disorder. Cerebral Cortex [Epub ahead of print] DOI: 10.1093/cercor/bhx319

6. Kato T, *Furukawa TA, Mantani A, Kurata K, Kubouchi H, Hirota S, Sato H, Sugishita K, Chino B, Itoh K, Ikeda Y, Shinagawa Y, Kondo M, Okamoto Y, Fujita H, Suga M, Yasumoto S, Tsujino N, Inoue T, Fujise N, Akechi T, Yamada M, Shimodera S, Watanabe N, Inagaki M, Miki K, Ogawa Y, Takeshima N, Hayasaka Y, Tajika A, Shinohara K, Yonemoto N, Tanaka S, Zhou Q, Guyatt GH; SUN☺D Investigators. Optimising first- and second-line treatment strategies for untreated major depressive disorder - the SUN☺D study: a pragmatic, multi-centre, assessor-blinded randomised controlled trial. BMC Med. 16(1):103, 2018. doi: 10.1186/s12916-018-1096-5. PubMed PMID: 29991347.

7. *Azuma K, Takaesu Y, Soeda H, Iguchi A, Uchida K, Ohta S, Mishima S, Inoue T, Inoue Y, Oda J: Ability of suvorexant to prevent delirium in patients in the intensive care unit: a randomized controlled trial. Acute Medicine & Surgery 5(4):362-368, 2018.  DOI:10.1002/ams2.368

8. Uchida Y, Takahashi T, Katayama S, Masuya J, Ichiki M, Tanabe H, Kusumi I, *Inoue T: Influence of trait anxiety, child maltreatment, and adulthood life events on depressive symptoms. Neuropsych. Dis. Treat.14: 3279-3287, 2018. DOI: 10.2147/NDT.S182783

9. Takeshima M*: Anxious distress in monopolar and bipolar depression: Clinical characteristics and relationship with mixed depression in Japan. [letter to the editor] Psychiatry and Clinical Neurosciences 72(6): 456-457, 2018. DOI: 10.1111/pcn.12660

10. Yamanaka Y, Terao T, Otsuka A, Hoaki N: Aripiprazole and valproate combination for chronic schizophrenia with dental treatment: a case report.  Clin Neuropsychopharmacol Ther 9:15-16, 2018.

11. Sugiura K, Shimura A: How does schema affect stress and productivity at the workplace?: quantitative analysis of schema in the occupational setting. Int J Prod Manag Assess Tech 6(2):19-38, 2018. DOI: 10.4018/IJPMAT.2018070102